As of 2024-12-14, the EV/EBITDA ratio of Sire Bioscience Inc (SIRE.CN) is -46.84. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. SIRE.CN's latest enterprise value is 64.76 mil CAD. SIRE.CN's TTM EBITDA according to its financial statements is -1.38 mil CAD. Dividing these 2 quantities gives us the above SIRE.CN EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 19.3x - 25.9x | 24.1x |
| Forward P/E multiples | 15.0x - 21.7x | 18.8x |
| Fair Price | (0.20) - (0.22) | (0.22) |
| Upside | -154.0% - -159.7% | -159.1% |
| Date | EV/EBITDA |